Figure 2.

Comparison of pure-tone thresholds measured on three separate visits in control (left) and cisplatin-treated subjects (right). Data are for SRO frequencies normalized to each subject’s highest audible frequency, F, defined during the baseline test. F-1 is ⅙ octave below F, F-2 is ⅙ octave below F-1, etc. Mean and standard error for thresholds at SRO frequencies are given.